Available worldwide · Popular in: GB
What is OpenEyes?
An open source electronic patient record application for ophthalmology practices. Built to run in web browsers, it provides clinicians with fast and intuitive access to patient information from any location, used across NHS and independent eye care settings.
OpenEyes pricing
We don't have OpenEyes's full plan breakdown yet (its pricing page resisted automated reading). Here's what we could confirm. Always check live pricing for exact numbers.
Free open source software under GNU Affero GPL v3.0 license
What OpenEyes does
The capabilities that matter for optometry software, normalised so it lines up with every alternative. “-” means we haven't confirmed it, not that it's missing.
- Deployment model
- Cloud web app
- Optical point of sale and frame inventory
- ✗
- Vision insurance vsp eyemed clearinghouse
- ✗
- Major medical insurance medicare clearinghouse
- ✗
- Autorefractor lensometer hardware integration
- ✓
- Contact lens catalog and prescription management
- ✗
- Ophthalmology surgical co management portal
- ✗
- Patient appointment scheduling and SMS reminders
- ✗
- DICOM fundus retinal camera image storage
- ✗
- HIPAA baas business associate agreement
- ✗
- SOC2 type ii
- ✗
- ISO 27001
- ✗
- Pricing model
- -
Platform & deployment
Independently observed- Web
- Self-hosted
Integrations (3)
Independently observed- OCT machines
- Visual field devices
- PAS systems
OpenEyes alternatives
Other optometry software we track, ranked by the same independent score.
Compare OpenEyes
Side by side against other optometry software, attribute by attribute, with a source on every value.
The Vioscale score: one lens on the evidence
Not user reviews and not a paid placement: a confidence-weighted blend of the independent signals below (adoption, activity, security posture, and more), which you can sort and re-weight yourself. Vendors can correct their listing but can never move their rank, and stars are weighted low as a vanity metric. It is one way to read the evidence for OpenEyes, not the verdict.
| Signal | Score | Weight | Contribution | Evidence |
|---|---|---|---|---|
| Pricing transparency | 80 | 0.08 | 6.7 | ✓ |
| Price level | 100 | 0.05 | 5.2 | ✓ |
| Capabilities | 29 | 0.08 | 2.4 | ✓ |
| Integrations | 17 | 0.09 | 1.6 | ✓ |
| Stars | 38 | 0.03 | 1.0 | ✓ |
| Reliability | 0 | 0.07 | 0.0 | - |
| Dependent projects | 0 | 0.06 | 0.0 | - |
| Development activity | 0 | 0.09 | 0.0 | ✓ |
| Release cadence | 0 | 0.05 | 0.0 | - |
| Security posture | 0 | 0.07 | 0.0 | - |
| Package downloads | 0 | 0.14 | 0.0 | - |
| Security score | 0 | 0.04 | 0.0 | - |
| Developer Q&A activity | 0 | 0.06 | 0.0 | - |
Computed . Re-weight it by intent, or see the full method.
All data & sourcesshow ↓
Every value we hold, with its source, retrieval date, and confidence. This is the evidence behind the score: don't trust it, verify it.
Activity
| Attribute | Value | Evidence |
|---|---|---|
| Commits last 30d | 0 | mediumsource · 2026-08-26 · 65% |
Adoption
| Attribute | Value | Evidence |
|---|---|---|
| Github stars | 99 | highsource · 2026-08-26 · 90% |
Features
| Attribute | Value | Evidence |
|---|---|---|
| Capabilities | Iso 27001: No · Soc2 type ii: No · Deployment model: cloud_web_app · Hipaa baas business associate agreement: No · Dicom fundus retinal camera image storage: No · Optical point of sale and frame inventory: No | mediumsource · 2026-08-21 · 60% |
Integrations
| Attribute | Value | Evidence |
|---|---|---|
| Count | 3 | mediumsource · 2026-08-21 · 60% |
Language
| Attribute | Value | Evidence |
|---|---|---|
| Primary | PHP | highsource · 2026-08-26 · 90% |
License
| Attribute | Value | Evidence |
|---|---|---|
| Spdx | AGPL-3.0 | highsource · 2026-08-26 · 95% |
Market
| Attribute | Value | Evidence |
|---|---|---|
| Availability | HqCountry: GB · PrimaryMarkets: … · AvailabilityScope: global · AvailableCountries: … · NotAvailableCountries: … | highsource · 2026-08-21 · 75% |
Pricing
Release
| Attribute | Value | Evidence |
|---|---|---|
| History | 20 items | mediumsource · 2026-08-26 · 70% |